Continuous surveillance of invasive pneumococcal disease is key

Mirjam J. Knol; Arie van der Ende

doi:https://doi.org/10.1016/S1473-3099(20)30294-2

Continuous surveillance of invasive pneumococcal disease is key

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Original language	English
Pages (from-to)	13-14
Number of pages	2
Journal	Lancet infectious diseases
Volume	21
Issue number	1
Early online date	2020
DOIs	https://doi.org/10.1016/S1473-3099(20)30294-2
Publication status	Published - Jan 2021

Access to Document

https://doi.org/10.1016/S1473-3099(20)30294-2

Cite this

@article{36a7f404fe0044bfa30c9c4d1429266f,

title = "Continuous surveillance of invasive pneumococcal disease is key",

author = "Knol, {Mirjam J.} and {van der Ende}, Arie",

note = "Funding Information: MJK has nothing to declare. AvdE has received a grant from Pfizer for research on pneumococcal infections (Investigator Initiated project “Epidemiology of invasive pneumococcal disease”, IIR WI173197), participated in advisory boards of Pfizer, and does consultancy activities for GlaxoSmithKline (fees paid to Amsterdam University Medical Center).",

year = "2021",

month = jan,

doi = "https://doi.org/10.1016/S1473-3099(20)30294-2",

language = "English",

volume = "21",

pages = "13--14",

journal = "Lancet infectious diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Continuous surveillance of invasive pneumococcal disease is key

AU - Knol, Mirjam J.

AU - van der Ende, Arie

N1 - Funding Information: MJK has nothing to declare. AvdE has received a grant from Pfizer for research on pneumococcal infections (Investigator Initiated project “Epidemiology of invasive pneumococcal disease”, IIR WI173197), participated in advisory boards of Pfizer, and does consultancy activities for GlaxoSmithKline (fees paid to Amsterdam University Medical Center).

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85089291349&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S1473-3099(20)30294-2

DO - https://doi.org/10.1016/S1473-3099(20)30294-2

M3 - Comment/Letter to the editor

C2 - 32702304

SN - 1473-3099

VL - 21

SP - 13

EP - 14

JO - Lancet infectious diseases

JF - Lancet infectious diseases

IS - 1

ER -

Continuous surveillance of invasive pneumococcal disease is key

Access to Document

Other files and links

Cite this